Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Dumpit

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cancer Research|February 19, 2009
Conserved gene expression programs integrate mammalian prostate development and tumorigenesisColin Pritchard, Brig Mecham, Ruth Dumpit, et al.
Genome Biology|December 9, 2003
Expressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostateDenise E Abbott, Colin Pritchard, Nigel J Clegg, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancerGalina Semenova, Sander Frank, Ruth Dumpit, et al.
Cancer Genetics|January 29, 2013
A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancerXiaoyu Qu, Grace Randhawa, Cynthia Friedman, et al.
The Prostate|January 11, 2022
Paracrine Wnt signaling is necessary for prostate epithelial proliferationXing Wei, Martine P Roudier, Oh-Joon Kwon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosisDaniel W Lin, Ilsa M Coleman, Sarah Hawley, et al.
The Journal of Clinical Investigation|June 25, 2026
Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancerGalina Semenova, Sander B Frank, Ruth Dumpit, et al.
The Prostate|January 22, 2013
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastasesSandy R Larson, Xiaotun Zhang, Ruth Dumpit, et al.
Cell Stem Cell|April 16, 2019
Spatially Restricted Stromal Wnt Signaling Restrains Prostate Epithelial Progenitor Growth through Direct and Indirect MechanismsXing Wei, Li Zhang, Zhicheng Zhou, et al.
Nature Communications|November 11, 2022
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunityDeyong Jia, Zhicheng Zhou, Oh-Joon Kwon, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cancer Research|February 19, 2009
Conserved gene expression programs integrate mammalian prostate development and tumorigenesisColin Pritchard, Brig Mecham, Ruth Dumpit, et al.
Genome Biology|December 9, 2003
Expressed sequence tag profiling identifies developmental and anatomic partitioning of gene expression in the mouse prostateDenise E Abbott, Colin Pritchard, Nigel J Clegg, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancerGalina Semenova, Sander Frank, Ruth Dumpit, et al.
Cancer Genetics|January 29, 2013
A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancerXiaoyu Qu, Grace Randhawa, Cynthia Friedman, et al.
The Prostate|January 11, 2022
Paracrine Wnt signaling is necessary for prostate epithelial proliferationXing Wei, Martine P Roudier, Oh-Joon Kwon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosisDaniel W Lin, Ilsa M Coleman, Sarah Hawley, et al.
The Journal of Clinical Investigation|June 25, 2026
Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancerGalina Semenova, Sander B Frank, Ruth Dumpit, et al.
The Prostate|January 22, 2013
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastasesSandy R Larson, Xiaotun Zhang, Ruth Dumpit, et al.
Cell Stem Cell|April 16, 2019
Spatially Restricted Stromal Wnt Signaling Restrains Prostate Epithelial Progenitor Growth through Direct and Indirect MechanismsXing Wei, Li Zhang, Zhicheng Zhou, et al.
Nature Communications|November 11, 2022
Stromal FOXF2 suppresses prostate cancer progression and metastasis by enhancing antitumor immunityDeyong Jia, Zhicheng Zhou, Oh-Joon Kwon, et al.
Pageof 3